Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis

Table 3

SMD, heterogeneity, and publication bias for liver function and fibrosis before and after FZHY treatments.

Parameters	Treatments	SMD ( value)	Heterogeneity			( value)
			Chi-squared	-squared	value
ALT	Before	0.321	7.61	0.212	0.268	0.230
	After	0.003	107.21	0.944	0.000	0.230
AST	Before	0.714	1.78	0.000	0.879	0.452
	After	0.084	15.83	0.684	0.007	0.452
TBil	Before	0.335	5.31	0.247	0.257	0.806
	After	0.001	93.31	0.957	0.000	0.806
ALB	Before	0.001	5.86	0.147	0.320	1.000
	After	0.037	207.03	0.976	0.000	0.452
HA	Before	0.150	1.71	0.000	0.999	0.837
	After	0.000	110.45	0.900	0.000	0.115
LN	Before	0.907	1.63	0.000	0.998	0.640
	After	0.000	109.31	0.909	0.000	0.161
PC-III	Before	0.716	9.25	0.000	0.509	0.043
	After	0.000	275.96	0.964	0.000	0.020
VI-C	Before	0.053	5.00	0.000	0.891	0.533
	After	0.000	53.25	0.812	0.000	0.161